Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility

American Journal of Roentgenology

Volumn 202, Issue 4, 2014, Pages 928-932

  Destounis, Stamatia V ^a   Arieno, Andrea L ^a   Morgan, Renee C ^a   Cavanaugh, David ^b   Seifert, Posy J ^a   Murphy, Philip F ^a   Somerville, Patricia A ^a  

^a Elizabeth Wende Breast Care LLC   (United States)

^b NONE

Author keywords

Breast cancer; Breast imaging; Screening mammography

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SURGERY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; PRIORITY JOURNAL; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGE FACTORS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84897010875     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11194     Document Type: Article

References (35)

1. American Cancer Society website. Cancer facts & Figures, 2011. www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/ cancer-facts-figures-2011. Accessed December 17, 2013
2. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151:716-726
3. Bjurstam N, Bjorneld L, Duffy S, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997; 80:2091-2099 (Pubitemid 27506022)
4. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö Mammographic Screening Trial. BMJ 1988; 297:943-948
5. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997; 1997:87-92
6. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40 to 49 years: current evidence from randomized controlled trials. Cancer 1995; 75:1619-1626
7. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up - a randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002; 137(5 Pt 1):305-312 (Pubitemid 34977131)
8. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007; 146:516-526 (Pubitemid 351650561)
9. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010; 363:1203-1210
10. Jørgensen KJ, Zahl PH, Gotzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010; 340:c1241
11. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009; 151:738-747
12. Coldman A, Philips N, Warren L, Kan L. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 2007; 120:1076-1080 (Pubitemid 46214308)
13. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367:1998-2005
14. Feig SA. Increased benefit from shorter screening mammography intervals for women ages 40-49 years. Cancer 1997; 80:2035-2039 (Pubitemid 27506015)
15. Tabár L, Vitak B, Chen TH, et al. Swedish Two County Trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011; 260:658-663
16. Tabár L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 325:829-832
17. Kerlikowske K, Grady D, Rubin S, Sandrock C, Ernster V. Efficacy of screening mammography: a meta-analysis. JAMA 1995; 273:149-154
18. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR 2011; 196:[web]W112-W116
19. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. Cancer 2011; 117:714-722
20. Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology 2012; 262:797-806
21. Curpen BN, Sickles EA, Sollitto RA, Ominsky SH, Galvin HB, Frankel SD. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR 1995; 164:1099-1103
22. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmö mammographic screening program. J Natl Cancer Inst Monogr 1997; 22:63-67
23. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993; 341:973-978 (Pubitemid 23109165)
24. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 2002; 359:909-919 (Pubitemid 34246378)
25. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39:2772-2782 (Pubitemid 8130392)
26. Kopans DB. The breast cancer screening controversy and the National Institutes of Health Consensus Development Conference on Breast Cancer Screening for Women Ages 40-49. (editorial) Radiology 1999; 210:4-9 (Pubitemid 29004276)
27. Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin 2000; 50:312-336
28. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:347-360 (Pubitemid 34977137)
29. Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomized controlled trial. Lancet 2006; 368:2053-2060 (Pubitemid 44855105)
30. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm: design, first round results and comparisons. Breast Cancer Res Treat 1986; 8:45-54 (Pubitemid 17186663)
31. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993; 270:2444-2450 (Pubitemid 23342293)
32. Kerlikowske K, Carney PA, Geller B, et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 2000; 133:855-863
33. Halapy EE, Chiarelli AM, Klar N, Knight J. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer. J Med Screen 2004; 11:32-38 (Pubitemid 38365693)
34. National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. NCCN Version 1.2012. infoonco.es/wp-content/uploads/2011/10/breast-cancer-2.2013.pdf. Published April 19, 2013. Accessed December 17, 2013
35. Macmillan RD. Screening women with a family history of breast cancer: results from the British Familial Breast Cancer Group. Eur J Surg Oncol 2000; 26:149-152